About 10% of women have Polycystic Ovary Syndrome (PCOS) and a further 10% have polycystic or multi-cystic ovaries on ultra sound scan. PCOS is a significant problem in fertility and long term health as it puts women at a five-fold increase of developing type 2 diabetes
PCOS is usually diagnosed by:
anovulation (failure to release an egg)
polycystic ovaries on scan
raised testosterone levels
However, a woman with PCOS may not have all these problems. In fact PCOS patients are not all the same! They frequently struggle to maintain a healthy weight (BMI 20 to 25), notice they are troubled by ‘teenage’ acne and may have excessive facial and body hair.
65 to 80% of women diagnosed with PCOS will have increased insulin resistance and new research suggests that this feature is responsible for many of the features associated with PCOS, including infertility and an increased risk of miscarriage.
Clinical trials have shown that Inofolic supplementation increases insulin sensitivity by 84% and helps with weight loss. It produces ovulation in the majority of women with anovulation due to PCOS and helps ovulation in women who fail to respond to Clomid.
Taken during IVF treatment it has been shown to improve egg and embryo quality and reduce the risk of OHSS. It can be taken throughout pregnancy and reduces the incidence of gestational diabetes (GDM).
There are many pharmacological preparations used alongside IVF medications to help with insulin sensitivity (eg Metformin). Unlike these medications, Inofolic is of vegetable origin (with no gluten or lactose) and has no unpleasant side effects such as abdominal cramps, bloatedness and diarrhoea.